@prefix chebi: . @prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix species: . @prefix occursIn: . @prefix obo: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 occursIn: obo:CL_0000169, obo:EFO_0002795, obo:UBERON_0001898, species:10116; rdf:object chebi:15551; rdf:predicate belv:increases; rdf:subject schem:serum%20leptin; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:\"serum leptin\") -> a(SCHEM:Dinoprostone)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_3; pav:version "20131211" . sub:_2 prov:value "These may be relevant in the pathogenesis of cardiovascular complications associated with obesity, such as atherosclerosis, and demand further investigation. Leptin stimulates prostaglandin E2 and prostaglandin F2a production in rat hypothalamic cells [111]."; prov:wasQuotedFrom pubmed:12020765 . sub:_3 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12020765; prov:wasDerivedFrom beldoc:, sub:_2 . } sub:pubinfo { this: dct:created "2014-07-03T14:31:49.265+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }